Norry Elliot's Form 4 filing
Adaptimmune Therapeutics PLC (ADAPY) · filed Jan 17, 2024
- Accession no.
- 0001104659-24-004563
- Filed
- Jan 17, 2024
- Trade date
- Jan 16-17, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $14.1K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Norry ElliotCIK 0001798117 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 16, 2024 | American Depositary Shares representing Ordinary Shares | SSaleDisposed | −2,287 | $0.79 | −$1,806.73 | 3,363 | Direct | |
| Jan 17, 2024 | American Depositary Shares representing Ordinary Shares | SSaleDisposed | −5,309 | $0.67 | −$3,557.03 | 7,785 | Direct | |
| Jan 17, 2024 | American Depositary Shares representing Ordinary Shares | SSaleDisposed | −12,967 | $0.67 | −$8,687.89 | 19,257 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.